TriSalus Life Sciences Ratios (2021-2026) | TLSI

Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 82.13%74.71%77.82%83.26%88.66%89.83%84.96%87.62%86.34%85.28%83.69%83.93%83.52%86.66%86.18%
EBT Margin (Quarter) -206.30%-698.57%-277.25%-302.71%-27.44%-622.93%-204.48%-58.73%-32.68%-122.37%-113.12%-73.94%-93.43%-73.86%17.34%
EBIT Margin (Quarter) -206.76%-364.91%-339.18%-247.92%-358.48%-249.05%-180.77%-111.00%-118.91%-91.76%-79.95%-65.39%-77.94%-24.77%-94.52%
EBITDA Margin (Quarter) -206.76%-364.91%-339.18%-247.92%-358.48%-249.05%-180.77%-111.00%-118.91%-91.76%-79.95%-65.39%-77.94%-24.77%-94.52%
Operating Margin (Quarter) -206.76%-364.91%-339.18%-247.92%-358.48%-249.05%-180.77%-111.00%-118.91%-91.76%-79.95%-65.39%-77.94%-24.77%-94.52%
Net Margin (Quarter) -206.30%-786.45%-309.22%-346.83%-36.26%-636.93%-216.93%-69.70%-43.57%-131.84%-120.94%-80.28%-356.86%-73.86%17.29%
FCF Margin (Quarter) -583.23%-263.92%-352.21%-200.93%-420.57%-166.91%-168.30%-182.27%-147.60%-73.26%-57.30%-58.74%-32.44%-18.85%-74.40%
Efficiency
Inventory Average (Quarter) 2.09M2.73M3.18M3.72M4.02M4.11M3.98M3.54M3.18M3.43M
Assets Average (Quarter) 250.47M250.48M250.94M136.66M21.26M16.38M22.90M29.08M21.24M25.16M29.95M25.72M26.30M34.97M38.89M35.90M53.16M
Equity Average (Quarter) -133.48M-141.66M-149.94M-165.53M-180.83M-191.47M-95.06M-9.39M-31.55M-30.65M-22.85M-23.16M-30.13M-26.90M-23.07M-30.29M-10.53M
Invested Capital (Quarter) -129.60M-137.35M-145.96M-153.93M-174.68M-179.87M-188.37M8.29M-27.07M-36.04M-3.98M1.24M-3.81M-2.67M12.85M6.04M-0.81M45.89M
Asset Utilization Ratio (Quarter) 0.900.700.641.030.980.901.141.221.031.031.260.84
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-9.32-7.65-7.10-6.06-5.15-6.17-2.25-5.86
Debt to Equity (Quarter) -0.01-0.03-0.05-0.84-1.06-0.85-0.92-1.66-1.23-0.982.58
Debt Ratio (Quarter) 0.110.230.820.660.790.921.110.780.900.940.47
Equity Ratio (Quarter) -0.52-0.55-0.58-0.61-8.05-8.99-16.210.25-1.10-2.01-0.78-0.74-1.08-1.20-0.47-0.73-0.960.18
Times Interest Earned (Quarter) -0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-9.32-7.65-7.10-6.06-5.15-6.17-2.25-5.86
Valuation
Enterprise Value (Quarter) -0.07M-0.21M-9.41M-0.14M-0.10M-21.38M-11.78M-3.97M-16.48M-11.29M-8.53M-13.00M-26.49M-22.69M-20.44M-56.55M
Return Ratios
Return on Sales (Quarter) -0.02%-0.07%-0.03%-0.03%0.00%-0.06%-0.02%-0.01%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%
Return on Capital Employed (Quarter) -19.98%-182.56%-400.46%-382.19%-378.20%-817.14%-400.44%-213.78%-233.38%-218.78%-120.79%-111.70%-110.44%-67.75%
Return on Invested Capital (Quarter) 0.00%0.00%0.01%0.06%0.02%0.03%0.31%0.28%0.10%-0.06%-0.03%-0.10%-0.01%
Return on Assets (Quarter) 0.00%0.00%-0.02%-0.03%-0.02%-0.02%-0.03%-0.02%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%0.06%0.02%0.02%0.02%0.01%0.01%0.01%0.02%0.01%0.03%